Foundation Fighting Blindness FndFightingBlindness . The Foundation Fighting Blindness is committed to finding treatments and cures for blinding retinal diseases that affect more than 10 million people in the United States. To learn more, go to FightingBlindness.org. Foundation Fighting Blindness’s tracks News | ReNeuron Not Continuing Clinical Development of Cell-Based Therapy for RP by Foundation Fighting Blindness published on 2022-01-19T15:50:07Z Eye on the Cure Podcast | Episode 16: Actor Ben Mehl by Foundation Fighting Blindness published on 2022-01-07T20:36:03Z News | RD Fund Invests in SalioGen Therapeutics, Developer of Novel Gene Coding Technology by Foundation Fighting Blindness published on 2022-01-07T19:19:20Z News | ProQR Doses First Patients in Phase 2/3 Clinical Trials for its USH2A-Exon 13 RNA Therapy by Foundation Fighting Blindness published on 2021-12-17T16:32:28Z News | Ocugen to Launch Clinical Trial for Cross-Cutting RP Gene Therapy by Foundation Fighting Blindness published on 2021-12-13T15:30:28Z Eye on the Cure Podcast | Episode 15: Gordon Gund by Foundation Fighting Blindness published on 2021-12-09T14:36:48Z Eye on the Cure Podcast | Episode 14: Michael Kalberer by Foundation Fighting Blindness published on 2021-11-09T20:38:58Z Eye on the Cure Podcast | Episode 13: Dave Knop, PhD by Foundation Fighting Blindness published on 2021-11-01T18:12:22Z News | FDA Approves Genentech’s Susvimo for Treating Wet AMD by Foundation Fighting Blindness published on 2021-10-25T15:49:45Z
News | ReNeuron Not Continuing Clinical Development of Cell-Based Therapy for RP by Foundation Fighting Blindness published on 2022-01-19T15:50:07Z
Eye on the Cure Podcast | Episode 16: Actor Ben Mehl by Foundation Fighting Blindness published on 2022-01-07T20:36:03Z
News | RD Fund Invests in SalioGen Therapeutics, Developer of Novel Gene Coding Technology by Foundation Fighting Blindness published on 2022-01-07T19:19:20Z
News | ProQR Doses First Patients in Phase 2/3 Clinical Trials for its USH2A-Exon 13 RNA Therapy by Foundation Fighting Blindness published on 2021-12-17T16:32:28Z
News | Ocugen to Launch Clinical Trial for Cross-Cutting RP Gene Therapy by Foundation Fighting Blindness published on 2021-12-13T15:30:28Z
Eye on the Cure Podcast | Episode 15: Gordon Gund by Foundation Fighting Blindness published on 2021-12-09T14:36:48Z
Eye on the Cure Podcast | Episode 14: Michael Kalberer by Foundation Fighting Blindness published on 2021-11-09T20:38:58Z
Eye on the Cure Podcast | Episode 13: Dave Knop, PhD by Foundation Fighting Blindness published on 2021-11-01T18:12:22Z
News | FDA Approves Genentech’s Susvimo for Treating Wet AMD by Foundation Fighting Blindness published on 2021-10-25T15:49:45Z
